Modeling anthracycline-triggered vascular dysfunction
Active Definitive Contract Awarded Last action
- Contract number
- 80ARC022CA007
- Awardee
-
Brigham & Womens Hospital Inc. UEI QN6MS4VN7BD1 Part of Partners Healthcare System Incorporated
- Awarding agency
-
Ames Research Center
National Aeronautics and Space Administration
- Obligated
- $1,999,512
Award facts
- Opportunity
-
- NASA Research Announcement (NRA): Extended Longevity of 3D Tissues and Microphysiological Systems for Modeling of Acute and Chronic Exposures to Stressors Solicitation · NNH21ZDA015N · Posted May 27, 2021
- Contract value 100% obligated
- $1,999,512.00 Current and potential, with all options
- Completion date 82% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 9 offers Basic Research
- Pricing
- Firm Fixed Price
- Place of performance
- Boston, MA 02115, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $499,512 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $500,000 | |
| Definitize Change Order | $0 | |
| Funding Only Action | $500,000 | |
| Original award | $500,000 |
Show all 11
About this award
NASA Ames Research Center awarded a $2 million definitive contract to Brigham & Women's Hospital Inc. for development of long-lasting 3D neurovascular microphysiological systems to model chronic inflammation-mediated neurodegeneration and anthracycline-triggered vascular dysfunction on September 27, 2022, with an ultimate completion date of September 26, 2027.
The originating NASA-NIH-BARDA-FDA research announcement, posted May 27, 2021, sought proposals to develop 3D tissues and microphysiological systems with extended longevity of at least six months to model acute and chronic exposures to stressors. This award represents one of 6 to 10 principal investigator-led contracts funded across the multi-agency effort at up to $2 million per award over four years. Place of performance is Boston, MA.
The contract is priced firm fixed price. The Charles Stark Draper Laboratory, Inc., a non-profit research and development organization, provides engineering and vascular model expertise, including PREDICT96 hardware to extend vascular model longevity and study chemotherapeutic impacts on vascular health.
Government-invoiced labor in FY2023 totaled $500 thousand across 1,804 contractor hours and 0.9 FTEs, representing a derived government-paid hourly rate of $277.09 per hour. The prime self-performed all reported hours with no subcontractor labor invoiced.
Subawards
| Subcontractor | Amount | Awarded |
|---|---|---|
| The Charles Stark Draper Laboratory, Inc. | $679,321 |
Quick answers
Who was awarded contract 80ARC022CA007?
80ARC022CA007 was awarded to Brigham & Womens Hospital Inc. by Ames Research Center (National Aeronautics and Space Administration) on September 27, 2022.
How much is contract 80ARC022CA007 worth?
The government has obligated $1,999,512 on 80ARC022CA007.
Was contract 80ARC022CA007 competed?
The extent of competition for 80ARC022CA007 was full and open competition. The government received 9 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award